Angiotensin Receptor Blockers Can Reduce Incidence of Alzheimer's

A study published in the BMJ concludes:

Angiotensin receptor blockers are associated with a significant reduction in the incidence and progression of Alzheimer’s disease and dementia compared with angiotensin converting enzyme [ACE] inhibitors or other cardiovascular drugs in a predominantly male population.